Phase II Study of TRC102 in Combination with Temozolomide for Recurrent Glioblastoma

Grant

Date/time Interval

  • May 24, 2016 - May 23, 2018
  • Total Award Amount

  • 12000.00
  • Direct Costs

  • 8164.00
  • Sponsor Award Id

  • ABTC 1402
  • Contributor

  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Han, Xiaosi   Investigator  
  • Nabors M.D., Louis   Principal Investigator